| Financial Year |
March 31 2023 |
| Monetary Funds |
485,281,645.00 |
| Held-for-trading Financial Assets |
261,747,199.00 |
| Notes Receivable |
24,859,269.00 |
| Accounts Receivable |
163,854,921.00 |
| Advances to Suppliers |
19,931,243.00 |
| Other Receivables |
10,237,463.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
151,848,449.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,879,126.00 |
| Total Current Assets |
1,141,312,220.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,266,941.00 |
| Investment Properties |
-- |
| Fixed Assetes |
434,656,832.00 |
| Under-construction Projects |
66,547,860.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,924,819.00 |
| R&D expenses |
-- |
| Goodwill |
162,055.00 |
| Long-Term Deferred and Prepaid Expenses |
326,568.00 |
| Deferred Income Tax Assets |
16,625,717.00 |
| Other Non-Current Assets |
21,863,958.00 |
| Sub-Total of Non-Current Assets |
645,641,380.00 |
| Total Assets |
1,786,953,600.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
144,616,769.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,883,785.00 |
| Taxes Payable |
31,470,560.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
154,983,306.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,769,285.00 |
| Sub-Total of Current Liabilities |
424,659,394.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,638,958.00 |
| Total Liabilities |
433,298,352.00 |
| Paid-In Capital(Or Share Stock) |
430,330,300.00 |
| Capital Surplus |
271,175,268.00 |
| Surplus Reserve |
98,839,351.00 |
| LESS:Treasury Stock |
21,714,747.00 |
| Undistributed Profits |
575,025,076.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,353,655,248.00 |
| Owner's Equity（Stockholder's Equity） |
1,353,655,248.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,786,953,600.00 |
